Talha Badar and Team: New VTE Risk Prediction Model Validated for Asparaginase-Treated ALL
Talha Badar, Hematologist-Oncologist at Mayo Clinic Comprehensive Cancer Center, posted on X:
”Derivation and External Validation of a Venous Thromboembolism Risk Prediction Model in Asparaginase-Treated ALL
Happy to contribute in this effort by ALL NCTN:
High VTE rates persist in asparaginase-treated ALL despite prophylaxis.
Externally validated VTE risk model using D-dimer and hemoglobin at diagnosis.”
Read the full article here.
Title: Derivation and External Validation of a Venous Thromboembolism Risk Prediction Model in Asparaginase-Treated ALL
Authors: Daniela R. Anderson, Radhika Gangaraju, Wafik G. Sedhom, Eva N. Hamulyák, Tzu-Fei Wang, Kristen M O’Dwyer, Brian J. Carney, Chandrasekar Muthiah, Michaela Liedtke, Talha Badar, Shai Shimony, Renana Robinson, Kristen Sanfilippo, Andriy Derkach, Shira Naomi Dinner, Bart J. Biemond, David Nemirovsky, Leah A. Goldberg, Anjani D. Kapadia, Hannah Levavi, Michal Bar-Natan, Grace Van Hyfte, Karan Bansal, Marc Carrier, Jill Fulcher, Anke M. Gerrits, Mark R. Litzow, Selina M Luger, Guru Subramanian Guru Murthy, Marlise R. Luskin, Ofir Wolach, William Shomali, Jeffrey I. Zwicker, Wendy A Stock, Avi Leader
Stay updated with Hemostasis Today.
-
Feb 23, 2026, 17:34Bastu Odoka: Why Blood Should NOT be Left at the Bedside to ‘Warm’
-
Feb 23, 2026, 17:28Henry Burkitt: Patients Are Challenging How the Medicines Policy System Works in England
-
Feb 23, 2026, 16:50Mutaz Al‑Sabah: Interesting Webinar on FH in Women is Now Available to Watch
-
Feb 23, 2026, 16:36Stéphanie Roullet։ New Method to Explore Primary Haemostasis in Cirrhotic Patients
-
Feb 23, 2026, 16:33Salvatore Massimo Petrina: Top 5 Game-Changers in the AHA and ACC PE Guidelines
-
Feb 23, 2026, 16:21Azin Alizadehasl: Introducing the Second Edition of a New Book on Echocardiography and Cardiac MRI
-
Feb 23, 2026, 16:16Kalyan Roy: When and Why Blood Irradiation Matters in Transfusion Medicine
-
Feb 23, 2026, 15:59Ney Carter Borges: Antithrombotic Therapy in 2025 – A Precision-Based Pharmacologic Update
-
Feb 23, 2026, 15:54Alan Nurden: From Early Discoveries to New Therapeutic Advances in von Willebrand Disease